Paper40705331
Computed Tomographic Screening Intervals for Patients at Moderate Risk of Lung Cancer.
de Nijs K and 8 others. JAMA Netw Open, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Computed Tomographic Screening Intervals for Patients at Moderate Risk of Lung Cancer. Papers, record 40705331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40705331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Neoplasms | Major topic |
| Tomography, X-Ray Computed | Major topic |
| Early Detection of Cancer | Major topic |
| Mass Screening | Major topic |
| Humans | |
| Aged | |
| Male | |
| Female | |
| Middle Aged | |
| Cost-Benefit Analysis | |
| Aged, 80 and over | |
| Canada | |
| Quality-Adjusted Life Years | |
| Smoking | |
| United States | |
| Risk Factors |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U01 CA253858 | NCI NIH HHS | United States | U01CA253858 | PubMed |
Source NIH RePORTER
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36653232 | Patterns of Birth Cohort‒Specific Smoking Histories by Race and Ethnicity in the U.S. | Am J Prev Med | 2023 | https://conductscience.org/library/papers/36653232 | PubMed |
| 2 | 37792671 | Cost-effectiveness of risk-based low-dose computed tomography screening for lung cancer in Switzerland. | Int J Cancer | 2024 | https://conductscience.org/library/papers/37792671 | PubMed |
| 3 | 34673885 | Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening. | JAMA Oncol | 2021 | https://conductscience.org/library/papers/34673885 | PubMed |
| 4 | 33687470 | Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. | JAMA | 2021 | https://conductscience.org/library/papers/33687470 | PubMed |
| 5 | 31995683 | Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. | N Engl J Med | 2020 | https://conductscience.org/library/papers/31995683 | PubMed |
| 6 | 35989646 | Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study. | J Med Screen | 2022 | https://conductscience.org/library/papers/35989646 | PubMed |
| 7 | 34673888 | Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US. | JAMA Oncol | 2021 | https://conductscience.org/library/papers/34673888 | PubMed |
| 8 | 33687469 | Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. | JAMA | 2021 | https://conductscience.org/library/papers/33687469 | PubMed |
| 9 | 36436778 | Repeat Annual Lung Cancer Screening After Baseline Screening Among Screen-Negative Individuals: No-Cost Coverage Is Not Enough. | J Am Coll Radiol | 2023 | https://conductscience.org/library/papers/36436778 | PubMed |
| 10 | 37909874 | Assessing the impact of increasing lung screening eligibility by relaxing the maximum years-since-quit threshold: A simulation modeling study. | Cancer | 2024 | https://conductscience.org/library/papers/37909874 | PubMed |
| 11 | 39764179 | Benchmarking lung cancer screening programmes with adaptive screening frequency against the optimal screening schedules derived from the ENGAGE framework: a comparative microsimulation study. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/39764179 | PubMed |
| 12 | 34383299 | A risk-based framework for assessing real-time lung cancer screening eligibility that incorporates life expectancy and past screening findings. | Cancer | 2021 | https://conductscience.org/library/papers/34383299 | PubMed |
| 13 | 34668948 | Lung Cancer Screening Eligibility and Screening Patterns Among Black and White Adults in the United States. | JAMA Netw Open | 2021 | https://conductscience.org/library/papers/34668948 | PubMed |
| 14 | 37909877 | Screening for lung cancer: 2023 guideline update from the American Cancer Society. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/37909877 | PubMed |
| 15 | 21714641 | Reduced lung-cancer mortality with low-dose computed tomographic screening. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21714641 | PubMed |
| 16 | 36745885 | Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis. | Ann Intern Med | 2023 | https://conductscience.org/library/papers/36745885 | PubMed |
| 17 | 34164288 | Lung cancer screening in Europe: where are we in 2021? | Transl Lung Cancer Res | 2021 | https://conductscience.org/library/papers/34164288 | PubMed |
| 18 | 25670839 | Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study. | Med Decis Making | 2015 | https://conductscience.org/library/papers/25670839 | PubMed |
| 19 | 23064024 | How to increase uptake in oncologic screening: a systematic review of studies comparing population-based screening programs and spontaneous access. | Prev Med | 2012 | https://conductscience.org/library/papers/23064024 | PubMed |
| 20 | 38813448 | Projected effectiveness of lung cancer screening and concurrent smoking cessation support in the Netherlands. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/38813448 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42487098 | Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review. | Pharmacoeconomics | 2026 | https://conductscience.org/library/papers/42487098 | PubMed |
| 41833807 | Integrating Deep Learning of Low-Dose CT Imaging With Clinical Data for Lung Cancer Risk Prediction. | Chest | 2026 | https://conductscience.org/library/papers/41833807 | PubMed |
| 41499175 | Geospatial Analysis of Accredited Lung Cancer Screening Facilities in Florida Reveals Suboptimal Alignment with High-Risk Populations. | Cancer Res Commun | 2026 | https://conductscience.org/library/papers/41499175 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40705331
GET https://conductscience.org/api/papers/v1/40705331/references?page=2